A biopharmaceutical also called as a biological medical by-product, biologic is other pharmaceutical drug by-product produce in, draw out from, or semisynthesized from biological origin. Distinct from completely synthesized pharmaceuticals, they also contain vaccines, complete blood, blood products, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living drugs used in cell remedy. Biologics can be composed of sugars, proteins, nucleic acids, or compound combinations of these material, or can be living cells or tissues. They (or their precursors or material) are introvert from living origin—human, animal, plant, fungal, or microbial. They may be used in the two human beings and animal treatment.

  • Recombinant Protein Therapy
  • Thrombolytic Agents
  • Haematopoietic Growth Factors
  • Gene Therapy

Related Conference of Biopharmaceuticals

October 24-25, 2024

8th International Conference on Protein Engineering

Zurich, Switzerland

Biopharmaceuticals Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in